Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erithematosus in the Italian Setting- A Cost-Effectiveness Analysis
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1495
https://www.valueinhealthjournal.com/article/S1098-3015(13)03400-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1339
First Page :
A564
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03400-1&doi=10.1016/j.jval.2013.08.1495